Cargando…
Machine learning-based mortality prediction models for smoker COVID-19 patients
BACKGROUND: The large number of SARS-Cov-2 cases during the COVID-19 global pandemic has burdened healthcare systems and created a shortage of resources and services. In recent years, mortality prediction models have shown a potential in alleviating this issue; however, these models are susceptible...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360290/ https://www.ncbi.nlm.nih.gov/pubmed/37479990 http://dx.doi.org/10.1186/s12911-023-02237-w |
_version_ | 1785076072189001728 |
---|---|
author | Sharifi-Kia, Ali Nahvijou, Azin Sheikhtaheri, Abbas |
author_facet | Sharifi-Kia, Ali Nahvijou, Azin Sheikhtaheri, Abbas |
author_sort | Sharifi-Kia, Ali |
collection | PubMed |
description | BACKGROUND: The large number of SARS-Cov-2 cases during the COVID-19 global pandemic has burdened healthcare systems and created a shortage of resources and services. In recent years, mortality prediction models have shown a potential in alleviating this issue; however, these models are susceptible to biases in specific subpopulations with different risks of mortality, such as patients with prior history of smoking. The current study aims to develop a machine learning-based mortality prediction model for COVID-19 patients that have a history of smoking in the Iranian population. METHODS: A retrospective study was conducted across six medical centers between 18 and 2020 and 15 March 2022, comprised of 678 CT scans and laboratory-confirmed COVID-19 patients that had a history of smoking. Multiple machine learning models were developed using 10-fold cross-validation. The target variable was in-hospital mortality and input features included patient demographics, levels of care, vital signs, medications, and comorbidities. Two sets of models were developed for at-admission and post-admission predictions. Subsequently, the top five prediction models were selected from at-admission models and post-admission models and their probabilities were calibrated. RESULTS: The in-hospital mortality rate for smoker COVID-19 patients was 20.1%. For “at admission” models, the best-calibrated model was XGBoost which yielded an accuracy of 87.5% and F(1) score of 86.2%. For the “post-admission” models, XGBoost also outperformed the rest with an accuracy of 90.5% and F(1) score of 89.9%. Active smoking was among the most important features in patients’ mortality prediction. CONCLUSION: Our machine learning-based mortality prediction models have the potential to be adapted for improving the management of smoker COVID-19 patients and predicting patients’ chance of survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-023-02237-w. |
format | Online Article Text |
id | pubmed-10360290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103602902023-07-22 Machine learning-based mortality prediction models for smoker COVID-19 patients Sharifi-Kia, Ali Nahvijou, Azin Sheikhtaheri, Abbas BMC Med Inform Decis Mak Research BACKGROUND: The large number of SARS-Cov-2 cases during the COVID-19 global pandemic has burdened healthcare systems and created a shortage of resources and services. In recent years, mortality prediction models have shown a potential in alleviating this issue; however, these models are susceptible to biases in specific subpopulations with different risks of mortality, such as patients with prior history of smoking. The current study aims to develop a machine learning-based mortality prediction model for COVID-19 patients that have a history of smoking in the Iranian population. METHODS: A retrospective study was conducted across six medical centers between 18 and 2020 and 15 March 2022, comprised of 678 CT scans and laboratory-confirmed COVID-19 patients that had a history of smoking. Multiple machine learning models were developed using 10-fold cross-validation. The target variable was in-hospital mortality and input features included patient demographics, levels of care, vital signs, medications, and comorbidities. Two sets of models were developed for at-admission and post-admission predictions. Subsequently, the top five prediction models were selected from at-admission models and post-admission models and their probabilities were calibrated. RESULTS: The in-hospital mortality rate for smoker COVID-19 patients was 20.1%. For “at admission” models, the best-calibrated model was XGBoost which yielded an accuracy of 87.5% and F(1) score of 86.2%. For the “post-admission” models, XGBoost also outperformed the rest with an accuracy of 90.5% and F(1) score of 89.9%. Active smoking was among the most important features in patients’ mortality prediction. CONCLUSION: Our machine learning-based mortality prediction models have the potential to be adapted for improving the management of smoker COVID-19 patients and predicting patients’ chance of survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-023-02237-w. BioMed Central 2023-07-21 /pmc/articles/PMC10360290/ /pubmed/37479990 http://dx.doi.org/10.1186/s12911-023-02237-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sharifi-Kia, Ali Nahvijou, Azin Sheikhtaheri, Abbas Machine learning-based mortality prediction models for smoker COVID-19 patients |
title | Machine learning-based mortality prediction models for smoker COVID-19 patients |
title_full | Machine learning-based mortality prediction models for smoker COVID-19 patients |
title_fullStr | Machine learning-based mortality prediction models for smoker COVID-19 patients |
title_full_unstemmed | Machine learning-based mortality prediction models for smoker COVID-19 patients |
title_short | Machine learning-based mortality prediction models for smoker COVID-19 patients |
title_sort | machine learning-based mortality prediction models for smoker covid-19 patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360290/ https://www.ncbi.nlm.nih.gov/pubmed/37479990 http://dx.doi.org/10.1186/s12911-023-02237-w |
work_keys_str_mv | AT sharifikiaali machinelearningbasedmortalitypredictionmodelsforsmokercovid19patients AT nahvijouazin machinelearningbasedmortalitypredictionmodelsforsmokercovid19patients AT sheikhtaheriabbas machinelearningbasedmortalitypredictionmodelsforsmokercovid19patients |